Pharmed has sold Accuscience to Diploma PLC
May 2022 — Ireland and UK-based Accuscience has been sold by Pharmed to Diploma PLC.
Accuscience, based in Naas, Ireland, distributes life sciences and medtech equipment. It is a recognized leader in core market segments of the Irish healthcare sector, including clinical diagnostics, blood tracking, resuscitation and mobile/modular healthcare facilities. Through relationships with over 100 suppliers, it delivers a full continuum of value-add services in both Ireland and Northern Ireland, including to the HSE and the NHS.
Diploma is an international group supplying specialized products and services in the life sciences, seals and controls sectors across the UK, Northern Europe, North America and Australia.
Pharmed is a major healthcare and pharmaceutical services provider in Ireland and the UK offering a variety of tailor-made solutions to distribution, sales and marketing for the purpose of representing manufacturers of beauty, pharmaceutical and OTC products. With established global networks, Pharmed provides an extensive range of services to meet the strategic requirements of its partners.
Our role in the transaction
Oaklins’ team in Ireland provided corporate finance advice to Pharmed in this sell-side transaction as well as overall project management services to management and the board. This was a very competitive process with a number of serious bidders from multiple jurisdictions in Europe.
Talk to the deal team
Related deals
Life & Mobility has attracted investor Bolster Investment Partners
Life & Mobility, a leading developer and manufacturer of premium mobility and rehabilitation solutions, has welcomed Bolster Investment Partners as a new shareholder. The partnership provides Life & Mobility with a strong long-term partner to support the company’s next phase of growth, with a continued focus on product innovation, strengthening its leading market position and further international expansion. The company’s mission remains to enhance the mobility, independence and quality of life of end users through innovative, sustainable and circular mobility solutions designed for multiple life cycles.
Learn moreAsana Gruppe has sold selected outpatient service areas to Luzerner Kantonsspital
Luzerner Kantonsspital (LUKS) has acquired key parts of Asana Spital Menziken AG’s outpatient services from Asana Gruppe AG, including its ambulance service, primary care practice and ambulatory care center. The transaction supports the long-term continuity of local medical care in the Swiss Wynen and Seetal regions and ensures these services remain available close to patients’ homes.
Learn moreLaboratoires Herbolistique has received a majority investment from Yotta Capital Partners and co-investors
Laboratoires Herbolistique has received a majority investment from Yotta Capital Partners alongside co-investors Ouest Croissance, Sodero and CE IDF, with Bpifrance, Océans Participations and the management team reinvesting.
Learn more